Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises EQT on merger of FocusVision and Confirmit
Mandate

Vinge advises EQT on merger of FocusVision and Confirmit

January 08, 2021 Employment and Benefits Banking and Finance EU, Competition and Regulatory M&A

The Nordic-based PE-forms EQT and Verdance intends to merger their respective portfolio companies FocusVision and Confirmit.

FocusVision was acuiered by EQT 201t and provides software and services for market research. Confirmit was acquired by Verdane 2019 and provides solutions for, inter alia, customer experience and market research. The merger is subject to customary regulatory approvals. 

Vinge’s team consisted of partners Christina Kokko (M&A), Marcus Glader (EU & Competition) and Albert Wållgren (Banking & Finance) and associates Stina Bengtsson (M&A), Pauline Lagerstrand, (Banking & Finance), Ebba Svenburg (Employment), Emma Johansson, Sebastian Örndahl, Anna Grigorian, Xandra Ståhlberg and Alice Noguier (EU & Competition).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025